ADPT vs CPRT · rev $142.4M vs P/E 19, rev $3.51B
Adaptive Biotechnologies Corp (ADPT) versus Copart Inc (CPRT) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
Copart Inc (CPRT) is a specialty business services company listed on US.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
Latest reported CPRT revenue for 2026-04-30 was $3.51B. Net income was $1.16B. Revenue was up 54.3% from 2026-01-31 to 2026-04-30. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
ADPT currently screens at market cap $2.69B. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
Not investment advice. Open the ADPT and CPRT stock pages for the full models.
Not investment advice.